Plasma microRNA Signature as Predictive Marker of Clinical Response to Therapy During Multiple Sclerosis

Plasma microRNA Signature as Predictive Marker of Clinical Response to Therapy During Multiple Sclerosis

ABSTRACT Objective Despite the availability of effective therapies for Multiple Sclerosis (MS), the unpredictable nature of disease progression and the variability in individual treatment outcomes call for reliable biomarkers. This pilot study aims to investigate the potential of plasma circulating...

Full description

Saved in:
Bibliographic Details
Main Authors: Fortunata Carbone, Alessandra Colamatteo, Teresa Micillo, Gianmarco Abbadessa, Silvia Garavelli, Clorinda Fusco, Claudia Russo, Francesco Perna, Federica Garziano, Claudia La Rocca, Maria Mottola, Giorgia Teresa Maniscalco, Simona Bonavita, Antonio Luca Spiezia, Alessia Castiello, Roberta Lanzillo, Vincenzo Brescia Morra, Claudio Procaccini, Paola deCandia, Giuseppe Matarese
Format: Article
Language:English
Published: Wiley 2025-08-01
Series:Annals of Clinical and Translational Neurology
Subjects:
circulating microRNA
dimethyl fumarate (DMF)
multiple sclerosis
Online Access:https://doi.org/10.1002/acn3.70093
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/acn3.70093

Similar Items